Mumbai, Sept. 24 -- Crisil Ratings stated that the ratings continue to reflect the strong business and financial risk profile of the Clean Science group.

The company reported its highest-ever consolidated quarterly revenue of around Rs 264 crore in Q1 FY27, with growth driven by the continued scale-up of the HALS business, which contributed 22% of sales during the quarter.

The business profile has strengthened with reduced dependence on legacy products, increasing export penetration in HALS, strategic collaboration with Geneus Chem for advanced NOR-HALS technology and a long-term supply agreement with Kemin.

Operating performance remained healthy, with consolidated EBITDA margin of 37% despite supply-chain disruptions and raw material ...